Home/ Supplements/ Niacin/ V-Power Plus

V-Power Plus

product on market Tablet or Pill Nutrients for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 28% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains Niacin and Zinc, which support metabolic function and immune health. Eurycoma longifolia and Epimedium extract are included for their potential effects on libido, though research evidence for these botanicals is generally limited. The overall evidence coverage for this specific ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for V-Power Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
28%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

5 mg (31% DV)
Within RDA (0.4× RDA) 196 studies (A:5, B:63)
15 mg (136% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
Eurycoma longifolia
100 mg
Epimedium extract
50 mg
Cnidium, Powder
25 mg
Velvet Bean Extract
25 mg
Market median: 495.0mg (70 products)
Market median: 50.0mg (57 products) 17 studies — no high-quality reviews
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
Eleuthero Root Extract
15 mg
Oat Straw extract
50 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Market median: 300.0mg (122 products) 22 studies (A:0, B:7)
Chinese Yam extract
100 mg
Market median: 500.0mg (357 products) 1 studies — no high-quality reviews
25 mg
Market median: 500.0mg (143 products)
Tribulus Fruit, Seed Extract
15 mg
Muira Puama, Powder
15 mg

Other Ingredients

Calcium Carbonate Croscarmellose Sodium Microcrystalline Cellulose Stearic Acid Hydroxypropylmethylcellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions (Men): Take 1 tablet daily preferably with food 1 to 2 hours prior to physical activity or as directed by a healthcare professional.

Warnings & Precautions

Caution: Not for use by individuals under the age of 18 years.

Consult a healthcare professional before using this product if you have or have a family history of breast cancer, prostate cancer, prostate enlargement, heart disease, low "good" cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effect includes acne, hair loss, aggressiveness, irritability, and increased level of estrogen. Discontinue use and call a healthcare professional immediately if you experience rapid heartbeat, dizziness, blurred vision, flushed skin (niacin), or other symptoms.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, fish and crustacean shellfish.

Keep out of the reach of children

Do not use if seal is broken

Formulation Notes

Non-GMO formula for men

Non-GMO formula for men

Additional Information

Store in a cool, dry place

Metadata

Product Details

UPC / SKU8 50015 03629 3
DSLD Entry Date2022-08-23
Product TypeOther Combinations
FormTablet or Pill
BrandNutrients for Health
DSLD ID272624
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Nutrients for Health View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.